Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Kennedy

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 16, 2009
A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrinJ Phillip Kennedy, P Jeffrey Conn, Craig W Lindsley
Journal of Natural Products|September 20, 2008
Total synthesis and biological evaluation of the marine bromopyrrole alkaloid dispyrin: elucidation of discrete molecular targets with therapeutic potentialJ Phillip Kennedy, John T Brogan, Craig W Lindsley
The American Journal of Medicine|October 15, 2020
Urine for a Surprise!Austin J Price, Elizabeth Li, Phillip Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulatorsThomas M Bridges, J Phillip Kennedy, Corey R Hopkins, et al.
Journal of Combinatorial Chemistry|January 29, 2008
Application of combinatorial chemistry science on modern drug discoveryJ Phillip Kennedy, Lyndsey Williams, Thomas M Bridges, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2010
Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAMThomas M Bridges, J Phillip Kennedy, Meredith J Noetzel, et al.
Biochemistry|August 22, 2013
Surface reengineering of RPA70N enables cocrystallization with an inhibitor of the replication protein A interaction motif of ATR interacting proteinMichael D Feldkamp, Andreas O Frank, J Phillip Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAMThomas M Bridges, J Phillip Kennedy, Hyekyung P Cho, et al.
ACS Chemical Neuroscience|July 11, 2012
Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expressionNicole K Speed, Heinrich J G Matthies, J Phillip Kennedy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2010
Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasisSabrina D Robertson, Heinrich J G Matthies, W Anthony Owens, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|May 16, 2009
A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrinJ Phillip Kennedy, P Jeffrey Conn, Craig W Lindsley
Journal of Natural Products|September 20, 2008
Total synthesis and biological evaluation of the marine bromopyrrole alkaloid dispyrin: elucidation of discrete molecular targets with therapeutic potentialJ Phillip Kennedy, John T Brogan, Craig W Lindsley
The American Journal of Medicine|October 15, 2020
Urine for a Surprise!Austin J Price, Elizabeth Li, Phillip Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulatorsThomas M Bridges, J Phillip Kennedy, Corey R Hopkins, et al.
Journal of Combinatorial Chemistry|January 29, 2008
Application of combinatorial chemistry science on modern drug discoveryJ Phillip Kennedy, Lyndsey Williams, Thomas M Bridges, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2010
Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAMThomas M Bridges, J Phillip Kennedy, Meredith J Noetzel, et al.
Biochemistry|August 22, 2013
Surface reengineering of RPA70N enables cocrystallization with an inhibitor of the replication protein A interaction motif of ATR interacting proteinMichael D Feldkamp, Andreas O Frank, J Phillip Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAMThomas M Bridges, J Phillip Kennedy, Hyekyung P Cho, et al.
ACS Chemical Neuroscience|July 11, 2012
Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expressionNicole K Speed, Heinrich J G Matthies, J Phillip Kennedy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2010
Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasisSabrina D Robertson, Heinrich J G Matthies, W Anthony Owens, et al.
Pageof 3